drugset / Trial / NCT02602249
Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.
RandomizedParallel-groupOpen-labelTreatment
Summary
In this study, safety and effects of MUC1-gene-DC-CTL and MUC1-peptide-DC-CTL on human gastric cancer are going to be investigated.
Timeline
- Start
- 2017-10
- Primary completion
- 2019-04
- Completion
- 2020-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MUC1-gene-DC-CTL | Cell therapy | — | Other |
| Subject | MUC1-peptide-DC-CTL | Cell therapy | — | Other |